HighTower Advisors’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-32,500
Closed -$74K 3799
2023
Q2
$74K Sell
32,500
-2,000
-6% -$4.6K ﹤0.01% 3122
2023
Q1
$68K Sell
34,500
-14,000
-29% -$29K ﹤0.01% 3011
2022
Q4
$80K Buy
48,500
+9,500
+24% +$14.8K ﹤0.01% 2967
2022
Q3
$78K Buy
39,000
+20,100
+106% +$48.1K ﹤0.01% 2817
2022
Q2
$40K Buy
+18,900
New +$64.2K ﹤0.01% 2932

Other funds holding LIAN

HighTower Advisors's LIAN Position: Q3 2023 in Review

HighTower Advisors sold out of LianBio American Depositary Shares (LIAN) in Q3 2023, closing a stake of 32,500 shares — an estimated $74K sold.

HighTower Advisors first reported a position in LIAN in Q2 2022 and held it in 5 quarters. The position peaked at $80K in Q4 2022. 38 funds tracked by Wall St. Rank hold LIAN as of Q3 2023.

  • HighTower Advisors reported no remaining LianBio American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • HighTower Advisors sold 32,500 LianBio American Depositary Shares shares in Q3 2023, an estimated $74K.
  • HighTower Advisors first reported a position in LianBio American Depositary Shares in Q2 2022 and held it in 5 quarters.
  • HighTower Advisors's LianBio American Depositary Shares position peaked at $80K in Q4 2022.
  • 38 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2023.

Based on HighTower Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.